by Ethan Huff
(Health Secrets) The vaccine widely administered for H1N1, also known as “swine flu”, is linked to causing neurological damage in the form of Guillain-Barre syndrome. This is the finding of a new study published in the Journal of the American Medical Association (JAMA). The study results confirm several earlier studies in both the U.S. and U.K. that also linked the H1N1 vaccine to severe neurological damage.
[Sponsor link: Vaccine and Detoxification Healing Protocol]
Reuters Health reports that, for the new study, Philippe De Wals of Laval University in Quebec City and his colleagues evaluated rates of Guillain-Barre in Canadians during the six months following the initial roll out of H1N1 vaccine in Quebec. Upon review, the team says it observed a definite increase in Guillain-Barre cases associated with the vaccine.
For those who are unaware of what Guillain-Barre actually is, the condition is marked by an autoimmune reaction where the body’s immune system mistakenly attacks the nervous system as if it is a foreign invader. This attack can cause severe nerve inflammation, muscle weakness, paralysis, and even death. Guillain-Barre was also widely observed following the mass vaccination campaigns for swine flu back in 1976.
The Canadian study confirms what the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) determined about the H1N1 vaccine back in 2010. The agency, which is akin to the U.S. Food and Drug Administration (FDA) in the U.S., issued a public statement at that time admitting that the H1N1 vaccine is linked to “a slightly elevated risk of GBS.”)